Perkins Coie Trust CO Novartis Ag Transaction History
Perkins Coie Trust CO
- $434 Million
- Q4 2024
A detailed history of Perkins Coie Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Perkins Coie Trust CO holds 432 shares of NVS stock, worth $46,548. This represents 0.01% of its overall portfolio holdings.
Number of Shares
432
Previous 529
18.34%
Holding current value
$46,548
Previous $60,000
30.0%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,444Shares Held
132MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$872 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$753 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$601 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...